Press releases 2 August 2016

Alpine Skier Reprimanded for Presence of Methylphenidate

The Canadian Centre for Ethics in Sport (CCES) announced today that Emma Woodhouse, an alpine skier, has committed an anti-doping rule violation and has received a sanction of a reprimand. The athlete’s urine sample, collected during in-competition doping control on March 28, 2016, revealed the presence of methylphenidate, a prohibited stimulant.

Methylphenidate is classified as a ‘specific substance’ on the World Anti-Doping Agency Prohibited List, banned in-competition. Under the rules of the Canadian Anti-Doping Program (CADP), an athlete facing a first violation involving a ‘specified substance’ can seek to have the sanction reduced to a reprimand. Based on factors assessed, including the athlete’s degree of fault, the CCES proposed a sanction of a reprimand and no period of ineligibility.

In response to the CCES’ notification of the adverse analytical finding, Ms. Woodhouse waived her right to a hearing, acknowledged the anti-doping rule violation, and accepted the sanction of a reprimand proposed by the CCES. In compliance with rule 7.10 of the CADP, a copy of the CCES’ file outcome summary can be found at:

• This media release was originally published by the Canadian Centre for Ethics in Sport (CCES) on 28 July 2016. To access the original, please click here.

You may also like...

Pin It on Pinterest

Share This